Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03424694 Org: User:
Start: 06/22/15 End: 02/22/22 Due: 02/22/23

Audit and Feedback Interventions With Primary Care Nursing Teams

Phase: N/A Priority: Normal
NCT ID: NCT04043468 Org: User:
Start: 09/02/21 End: 09/02/24 Due: 09/02/25

Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy

Phase: N/A Priority: Normal
NCT ID: NCT04075955 Org: User:
Start: 04/29/19 End: 12/31/19 Due: 12/31/20

Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population

Phase: N/A Priority: Normal
NCT ID: NCT04756895 Org: User:
Start: 03/01/21 End: 08/06/21 Due: 08/06/22

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02045030 Org: User:
Start: 01/31/14 End: 11/30/16 Due: 11/30/17

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03862170 Org: User:
Start: 02/10/15 End: 02/28/23 Due: 02/28/24

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06690905 Org: User:
Start: 02/26/25 End: 12/19/25 Due: 12/19/26